Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Nuvo Pharmaceuticals Inc NRIFF


Primary Symbol: MRVFF

Nuvo Pharmaceuticals Inc is a Canadian focused healthcare company doing business as Miravo Healthcare with global reach and a diversified portfolio of commercial products. Its product targets several therapeutic areas, including pain, allergy, and dermatology. The company's strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets.


OTCQX:MRVFF - Post by User

Bullboard Posts
Post by VictorKonstanon Aug 08, 2018 1:10pm
219 Views
Post# 28428126

Q2 Conference Call

Q2 Conference CallDefinitely a much more positive quarter...things are finally looking up!
On the Q2 conference call, Jesse mentioned that they are in advanced and hopefully final discussions with two very interested companies to market and distribute Resultz in the U.S.  They wanted to have a U.S. partner in place by July, but wanted the best deal possible...he sounded very optimistic that a deal would be consummated soon.  No mention of possible Resultz partners for the other large markets in Europe, and he discussed the timeline in greater detail for P2 regulatory applications and commercial launches for the EU, and with Gebro in Switzerland.  Unfortunately, no mention of Sayre in India, and other jurisdictions such as Canada.  Nevertheless, it seems to take forever to acquire regulatory approval anywhere, and our patent clock is ticking!  Hopefully, Horizon will be more engaged and will continue to slowly ramp up sales in the U.S.  In addition, he did discuss and elaborate about possible accretive acquisitions in the future as well, and how reasonable the price points were.
Regarding what a possible deal for Resultz in the U.S. would entail, I'm assuming that Jesse would be looking for a small upfront payment along with a mid teens royalty revenue, and a manufacturing royalty as well.  Time to cross your fingers....


Bullboard Posts